Upgrade to SI Premium - Free Trial

Harmony Biosciences (HRMY)

42.25 +0.39 (0.93%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress September 3, 2026 8:05 AM - StreetInsider Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference August 27, 2026 8:05 AM - StreetInsider Wolfe Research Starts Harmony Biosciences Holdings Inc. (HRMY) at Outperform August 26, 2026 5:32 AM - StreetInsider Form 144 Harmony Biosciences Hold Filed by: Valor IV Pharma Holdings, LLC August 7, 2026 4:48 PM - SEC Filing Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium August 6, 2026 8:05 AM - StreetInsider Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer August 4, 2026 2:30 PM - StreetInsider Form 10-Q Harmony Biosciences Hold For: Jun 30 August 4, 2026 8:17 AM - SEC Filing Form 8-K Harmony Biosciences Hold For: Aug 04 August 4, 2026 8:05 AM - SEC Filing Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile August 4, 2026 7:30 AM - StreetInsider Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $51 at Mizuho August 3, 2026 6:36 AM - StreetInsider Form SCHEDULE 13G Harmony Biosciences Hold Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC July 31, 2026 11:24 AM - SEC Filing Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $51 at Mizuho July 31, 2026 6:53 AM - StreetInsider Form SCHEDULE 13G/A Harmony Biosciences Hold Filed by: BlackRock, Inc. July 28, 2026 4:47 PM - SEC Filing Form 3 Harmony Biosciences Hold For: Jul 16 Filed by: Mollichella Stephen M. July 22, 2026 4:04 PM - SEC Filing Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026 July 21, 2026 8:05 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) July 20, 2026 6:49 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) July 17, 2026 7:10 AM - StreetInsider Form 8-K Harmony Biosciences Hold For: Jul 16 July 16, 2026 8:35 AM - SEC Filing Harmony Biosciences posts record Q2 revenue, CFO steps down July 16, 2026 8:30 AM - StreetInsider Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition July 16, 2026 8:30 AM - BizWire Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY) July 8, 2026 6:38 AM - StreetInsider Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip July 2, 2026 4:07 PM - SEC Filing Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip June 30, 2026 4:05 PM - SEC Filing Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip June 26, 2026 4:19 PM - SEC Filing Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip June 24, 2026 4:19 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) June 24, 2026 6:43 AM - StreetInsider Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical June 11, 2026 3:03 PM - BizWire Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting June 11, 2026 8:05 AM - BizWire Full Article List